We are live on ! Find out more
PRAH

PRA Health Sciences, Inc.
PRAH

Delisted

PRAH was delisted on the 30th of June, 2021.

293 hedge funds and large institutions have $6.06B invested in PRA Health Sciences, Inc. in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 100 increasing their positions, 124 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

234% more call options, than puts

Call options by funds: $8.86M | Put options by funds: $2.65M

16% more capital invested

Capital invested by funds: $5.24B → $6.06B (+$821M)

3% less funds holding

Funds holding: 301293 (-8)

16% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 45

19% less repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 124

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
293
Holders Change
-8
Holders Change %
-2.66%
% of All Funds
6.01%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
38
Increased
100
Reduced
124
Closed
45
Calls
$8.86M
Puts
$2.65M
Net Calls
+$6.21M
Net Calls Change
+$1.74M
Name Holding Trade Value Shares
Change
Change in
Stake
BPM
201
Bowling Portfolio Management
Ohio
$593K -$2.33K -25 -0.4%
DTL
202
Dynamic Technology Lab
Singapore
$592K +$566K +6,081 New
HSBC Holdings
203
HSBC Holdings
United Kingdom
$583K -$152K -1,638 -21%
SAM
204
Shell Asset Management
Netherlands
$583K -$7.07K -76 -1%
SGAM
205
Smith Group Asset Management
Texas
$562K -$8.3M -89,190 -94%
WP
206
Woodline Partners
California
$543K +$519K +5,582 New
Truist Financial
207
Truist Financial
North Carolina
$542K -$126K -1,358 -20%
PHK
208
Point72 Hong Kong
Hong Kong
$535K +$512K +5,497 New
ECM
209
ExodusPoint Capital Management
New York
$534K +$511K +5,488 New
Janney Montgomery Scott
210
Janney Montgomery Scott
Pennsylvania
$517K -$32.4K -348 -6%
Susquehanna International Group
211
Susquehanna International Group
Pennsylvania
$479K -$569K -6,117 -55%
EWM
212
Executive Wealth Management
Michigan
$470K -$338K -3,633 -43%
VF
213
Virtu Financial
New York
$464K +$444K +4,773 New
OR
214
Olympiad Research
Connecticut
$449K +$430K +4,617 New
Arrowstreet Capital
215
Arrowstreet Capital
Massachusetts
$428K +$409K +4,400 New
PP
216
Paloma Partners
Connecticut
$428K +$409K +4,400 New
LIA
217
LS Investment Advisors
Michigan
$418K +$14.5K +156 +4%
SI
218
Shaker Investments
Ohio
$407K -$242K -2,600 -38%
CANY
219
Caxton Associates (New York)
New York
$401K +$383K +4,119 New
SBF
220
Sara-Bay Financial
Florida
$400K +$394K +4,230 New
MAM
221
Meeder Asset Management
Ohio
$387K -$408K -4,379 -52%
GAM
222
Gotham Asset Management
New York
$380K -$321K -3,451 -47%
CS
223
Comerica Securities
Michigan
$361K +$119K +1,276 +52%
SCM
224
Shelton Capital Management
Colorado
$359K -$31K -333 -8%
ACM
225
AlphaCrest Capital Management
New York
$349K -$351K -3,767 -51%

PRAH Hedge Fund Activity: Q2 2020 in Review

293 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q2 2020, worth a combined $6.06B — up 16% from $5.24B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of PRAH and 38 opened new positions — a net loss of 7 holders — while 124 trimmed existing stakes and 100 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $174M. The largest seller was Eagle Asset Management, cutting an estimated $51.5M.

  • 293 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q2 2020, down from 301 in Q1 2020.
  • Funds reported $6.06B of PRA Health Sciences, Inc. stock for Q2 2020, up 16% quarter-over-quarter.
  • 38 funds opened new PRA Health Sciences, Inc. positions in Q2 2020 and 45 closed out, a net change of -7 holders.
  • The largest PRA Health Sciences, Inc. buyer in Q2 2020 was Massachusetts Financial Services, an estimated $174M added.
  • The largest PRA Health Sciences, Inc. seller in Q2 2020 was Eagle Asset Management, an estimated $51.5M sold.

Based on aggregated 13F filings for Q2 2020.